Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822399) titled 'A Study of MGC030 in Participants With Advanced Solid Tumors' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: MacroGenics
Condition:
Urothelial Cancer
GastroEsophageal Cancer
Colorectal Cancer
Esophageal Cancer
Gastric Cancer (GC)
Pancreatic Cancer
Intervention:
Biological: MGC030
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2026
Target Sample Size: 314
To know more, visit https://clinicaltrials.gov/study/NCT07822...